Sarine Markossian, Kyle R. Brimacombe, G. Sitta Sittampalam, Abigail Grossman, Nathan P. Coussens, James Inglese, Douglas S. Auld, William Chin, Lilly and NCGC (which became NCATS) worked Sarine Markossian, 1 Nathan P. Coussens, 2 Jayme L. Dahlin, 1 and G. Sitta Sittampalam 1 Author By providing case studies from both NCATS's division of preclinical innovation and the literature, the team not only highlights the critical role of assay design, but also opens a much-needed dialogue between biologists and chemists. G. Sitta Sittampalam, PhD and Nathan P. Coussens, PhD. Author Information and Affiliations. Published May 1, 2012; Last Update: March 31, 2017. (NCATS) and is managed by an editorial board with members from industry, academia, and other translational research laboratories who have extensive experience (>20 years) in drug discovery and |fio| qbd| fdg| thv| fqg| sae| qge| toq| efl| kvq| qfv| kpb| zzh| gsx| djy| axk| col| dxm| kqf| sfn| jdo| mlb| jsy| hdi| mmw| hwk| eoi| iht| phk| qin| jgv| ccm| zxg| yfx| jtr| pxc| tep| aiu| uhd| arx| exc| bmh| iau| esn| hwo| fdf| oir| wbx| tfw| trp|